Results for: medical+device+division

Toshiba medical unit boss fired over accounting fraud

US approves handheld injector for painkiller overdose

BAT's novel e-cigarette rival wins UK medical approval

Sanofi bets on inhaled insulin with up to $925 million MannKind deal

J&J 4Q profit jumps on higher sales, lower charges

Sanofi bets on inhaled insulin with MannKind deal

Kaeser Wants New Model Insisting Goliath Still Is Siemens

GOP cautions that Senate control would have limits

Beleaguered caregivers getting help from apps

3 win chemistry Nobel for super-zoom microscopes

Veterans killed in train crash were war heroes

Texas firefighters focused concern on toxic gases

Obama wants to crack down on US firms' tax inversions

J&ampJ sees device growth via new products, emerging markets

Sony counts on 'selfies', video calls to drive image sensor growth

Sony reduces loss on sales recovery, restructuring

Pentagon bans 60 mm mortar round after deaths

Toshiba net profit down 34% as it eyes Alstom's power grid unit

U.S. Congress urged to pass bill to speed development of antibiotics

Hewlett-Packard's rise, fall and future

GE to buy Lufkin Industries for $3.1B

Reports of e-cigarette injury jump amid rising popularity

GE earnings expected to rise on sale of NBC

A look at Johnson & Johnson 1st-quarter sales

Siemens CEO shakes up company to raise profits

Medicine goes mobile with smartphone apps, devices

Philips: a phoenix with lessons for industrial lame ducks

Autopsy: QB died from pneumonia, had brain disease

AP IMPACT: Recession, tech kill middle-class jobs

Apple, Google, Samsung vie to bring health apps to wearables

J&J hikes 2014 forecast for a third time

Covidien fiscal 1Q profit slips, tops expectations

Mixed views on Samsung after stellar 2013

Republicans say FDA spying may have broken whistleblower law

US military deaths in Afghanistan at 2,045

Gene therapy scores big wins against blood cancers

Apple, Google, Samsung vie to bring health apps to wearables

In quest for next windfall, tech funds look to healthcare

Afghan troops hold their ground at high cost

Harvard Bioscience down after delaying unit's IPO

Republicans caution that Senate control has limits